1. A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study. Issue 10 (25th February 2021) Authors: Fangusaro, Jason; Onar-Thomas, Arzu; Poussaint, Tina Young; Wu, Shengjie; Ligon, Azra H; Lindeman, Neal; Campagne, Olivia; Banerjee, Anu; Gururangan, Sridharan; Kilburn, Lindsay B; Goldman, Stewart; Qaddoumi, Ibrahim; Baxter, Patricia; Vezina, Gilbert; Bregman, Corey; Patay, Zoltan; Jones, Jeremy... Journal: Neuro-oncology Issue: Volume 23:Issue 10(2021) Page Start: 1777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study. Issue 8 (21st March 2022) Authors: Fangusaro, Jason R; Onar-Thomas, Arzu; Poussaint, Tina Young; Wu, Shengjie; Ligon, Azra H; Lindeman, Neal Ian; Banerjee, Anuradha; Packer, Roger; Kilburn, Lindsay B; Pollack, Ian F; Qaddoumi, Ibrahim A; Fisher, Paul Graham; Dhall, Girish; Baxter, Patricia Ann; Kreissman, Susan G; Doyle, L Austin;... Journal: Neuro-oncology Issue: Volume 24:Issue 8(2022) Page Start: 1404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LGG-02. A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B. (23rd April 2019) Authors: Fangusaro, Jason; Onar-Thomas, Arzu; Poussaint, Tina Young; Wu, Shengjie; Ligon, Azra H; Lindeman, Neal; Banerjee, Anu; Packer, Roger J; Kilburn, Lindsay B; Goldman, Stewart; Pollack, Ian F; Jakacki, Regina I; Qaddoumi, Ibrahim; Fisher, Paul G; Dhall, Girish; Baxter, Patricia; Kreissman, Susa G; ... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 2 Page Start: ii98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. LGG-49. SAFETY AND EFFICACY OF TRAMETINIB (T) MONOTHERAPY AND DABRAFENIB + TRAMETINIB (D+T) COMBINATION THERAPY IN PEDIATRIC PATIENTS WITH BRAF V600-MUTANT LOW-GRADE GLIOMA (LGG). (4th December 2020) Authors: Bouffet, Eric; Whitlock, James A; Moertel, Christopher; Geoerger, Birgit; Aerts, Isabelle; Hargrave, Darren; Cohen, Kenneth J; Kilburn, Lindsay B; Upadhyaya, Santhosh A; Wetmore, Cynthia; Wright, Karen D; Choi, Jeea; Gasal, Eduard; Russo, Mark W; Fox, Elizabeth Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 3 Page Start: iii375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LTBK-01. UPDATES ON THE PHASE II AND RE-TREATMENT STUDY OF AZD6244 (SELUMETINIB) FOR CHILDREN WITH RECURRENT OR REFRACTORY PEDIATRIC LOW GRADE GLIOMA: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY. Issue 2 (1st July 2018) Authors: Fangusaro, Jason R; Onar-Thomas, Arzu; Poussaint, Tina Young; Wu, Shengjie; Ligon, Azra H; Lindeman, Neal Ian; Banerjee, Anuradha; Packer, Roger; Kilburn, Lindsay B; Pollack, Ian F; Qaddoumi, Ibrahim A; Fisher, Paul Graham; Dhall, Girish; Baxter, Patricia Ann; Kreissman, Susan G; Doyle, L Austin;... Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report. Issue 4 (4th August 2021) Authors: Su, Jack M; Kilburn, Lindsay B; Mansur, David B; Krailo, Mark; Buxton, Allen; Adekunle, Adesina; Gajjar, Amar; Adamson, Peter C; Weigel, Brenda; Fox, Elizabeth; Blaney, Susan M; Fouladi, Maryam Journal: Neuro-oncology Issue: Volume 24:Issue 4(2022) Page Start: 655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report. Issue 11 (12th May 2020) Authors: Goldman, Stewart; Pollack, Ian F; Jakacki, Regina I; Billups, Catherine A; Poussaint, Tina Y; Adesina, Adekunle M; Panigrahy, Ashok; Parsons, Donald W; Broniscer, Alberto; Robinson, Giles W; Robison, Nathan J; Partap, Sonia; Kilburn, Lindsay B; Onar-Thomas, Arzu; Dunkel, Ira J; Fouladi, Maryam Journal: Neuro-oncology Issue: Volume 22:Issue 11(2020) Page Start: 1696 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Issue 7 (July 2019) Authors: Fangusaro, Jason; Onar-Thomas, Arzu; Young Poussaint, Tina; Wu, Shengjie; Ligon, Azra H; Lindeman, Neal; Banerjee, Anuradha; Packer, Roger J; Kilburn, Lindsay B; Goldman, Stewart; Pollack, Ian F; Qaddoumi, Ibrahim; Jakacki, Regina I; Fisher, Paul G; Dhall, Girish; Baxter, Patricia; Kreissman, Sus... Journal: Lancet oncology Issue: Volume 20:Issue 7(2019) Page Start: 1011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗